Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-077432
Filing Date
2022-07-05
Accepted
2022-07-05 17:14:55
Documents
2
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2220248-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2220248-1_4seq1.xml 4 4151
2 EXHIBIT 24 tm2220248d1_ex24.htm EX-24 5909
  Complete submission text file 0001104659-22-077432.txt   11596
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Issuer) CIK: 0001175680 (see all company filings)

EIN.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CYTODYN INC. 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address
Kelly Scott A. (Reporting) CIK: 0001703394 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-49908 | Film No.: 221066331